文献速递眼整形与眼眶神经眼科

甲状腺相关眼病眼外肌中IGF1R与TSHR共表达研究

Coexpression of IGF1R and TSHR in extraocular muscles of patients with thyroid-associated orbitopathy.
PubMed 文献 · Br J Ophthalmol · 2026-09-18

该研究比较了甲状腺相关眼病(TAO)患者与先天性斜视对照者的眼外肌标本,发现TAO组纤维化更明显,且IGF1R与TSHR表达显著高于对照组,半定量分析显示两组表达面积差异有统计学意义(p<0.05)。结论提示IGF1R与TSHR可能参与TAO的眼眶成纤维细胞浸润与肌肉重塑,为IGF1R靶向治疗提供组织学依据。

要点

  • TAO患者眼外肌纤维化程度高于先天性斜视对照组。
  • TAO组IGF1R与TSHR表达显著高于对照组,多见于 elongated fibroblast-like cells 及部分肌细胞。
  • 半定量分析显示TAO组IGF1R与TSHR平均表达面积均显著大于对照组(p<0.05)。

核心结论

  • TAO患者眼外肌中IGF1R与TSHR表达升高,支持二者可能参与眼眶成纤维细胞浸润与肌肉重塑。

研究设计与样本

  • 获取TAO患者大角度斜视矫正行直肌截除术的眼外肌标本,以及先天性斜视对照行直肌切除术的眼外肌标本。
  • 采用免疫组化检测并比较组间IGF1R与TSHR表达,ImageJ软件评估染色面积,H&E染色评估组织形态差异。
  • 组间比较采用Mann-Whitney U检验;TAO组n=12,对照组n=6。

主要发现

  • 组织学检查显示TAO组眼外肌标本纤维化程度高于对照组。
  • 免疫组化显示TAO组IGF1R与TSHR表达显著高于对照组,对照组表达极少。
  • TAO组中IGF1R与TSHR高表达尤其见于 elongated fibroblast-like cells 及部分肌细胞。
  • 半定量分析证实TAO组IGF1R与TSHR平均表达面积显著大于对照组(p<0.05)。

关键数值与推荐

  • TAO组IGF1R与TSHR平均表达面积显著大于对照组,p<0.05。

临床怎么用

  • 研究结果为TAO相关眼外肌病理中IGF1R的生物学相关性提供组织学支持,可能有助于未来IGF1R靶向治疗(如teprotumumab)的探索。
  • 目前尚需进一步定量与机制研究以明确这些发现对治疗的启示。

局限性

  • 样本量较小(TAO组n=12,对照组n=6)。
  • 作者指出需进一步定量与机制研究来更好界定治疗意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To explore the roles of insulin-like growth factor 1 receptor (IGF1R) and thyroid-stimulating hormone receptor (TSHR) in extraocular muscle pathology. METHODS: Extraocular muscle specimens were obtained during rectus muscle myectomy surgeries performed for large-angle strabismus correction in patients with thyroid-associated orbitopathy (TAO) and during rectus muscle resection surgeries performed for congenital strabismus in normal controls. Immunohistochemistry was employed to detect and compare between-group IGF1R and TSHR expression; ImageJ software was used to assess the staining area and H&E staining was used to evaluate morphological differences in tissues. Intergroup comparisons were conducted using the Mann-Whitney U test. RESULTS: Histological examination of the extraocular muscle specimens revealed greater fibrosis in the TAO group (n=12) than in the control group (n=6). Immunohistochemistry (IHC) revealed significantly higher expression of both IGF1R and TSHR in the TAO group, particularly in elongated fibroblast-like cells and some myocytes, than in the control group, which exhibited minimal expression. Semiquantitative analysis confirmed significantly larger mean expression areas for IGF1R and TSHR in the TAO group than in the control group (p<0.05). CONCLUSIONS: Our study revealed elevated IGF1R and TSHR expression in the extraocular muscles of patients with TAO, supporting their potential involvement in orbital fibroblast infiltration and muscle remodelling in TAO. These findings provide tissue-based support for the biological relevance of IGF1R in TAO-related extraocular muscle pathology and may help inform future investigations of IGF1R-targeted therapies such as teprotumumab. Further quantitative and mechanistic studies are warranted to better define the therapeutic implications of these findings.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chen KY, Lin CC, Chen WJ, et al. Coexpression of IGF1R and TSHR in extraocular muscles of patients with thyroid-associated orbitopathy. Br J Ophthalmol. 2026. PMID: 42760102. doi:10.1136/bjo-2025-329199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。